Real-world analysis demonstrates high remission rates and a manageable safety profile of brexu-cel in patients with B-ALL Leukemia Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me
